Abstract
Borna Disease Virus (BDV) is a neurotropic RNA virus worldwide in distribution that causes movement, behavior or cognitive disorders in animal species. Borna Disease the illness ranges from asymptomatic to fatal meningoencephalitis across naturally infected warmblooded (mammalian and bird) species. There are also reported associations of the virus with neuropsychiatric diseases of man. Development of experimentally infected rodents, frequently rats, as models for examining behavioral, pharmacologic and biochemical responses to viral challenge at different stages of life have contributed to understanding the role of CNS viral injury in vulnerability to neurodevelopmental, behavioral and degenerative diseases.
Keywords: borna disease, virus, encephalitis, dopamine, serotonin, rat
Current Neuropharmacology
Title: Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection
Volume: 1 Issue: 4
Author(s): Marylou V. Solbrig and George F. Koob
Affiliation:
Keywords: borna disease, virus, encephalitis, dopamine, serotonin, rat
Abstract: Borna Disease Virus (BDV) is a neurotropic RNA virus worldwide in distribution that causes movement, behavior or cognitive disorders in animal species. Borna Disease the illness ranges from asymptomatic to fatal meningoencephalitis across naturally infected warmblooded (mammalian and bird) species. There are also reported associations of the virus with neuropsychiatric diseases of man. Development of experimentally infected rodents, frequently rats, as models for examining behavioral, pharmacologic and biochemical responses to viral challenge at different stages of life have contributed to understanding the role of CNS viral injury in vulnerability to neurodevelopmental, behavioral and degenerative diseases.
Export Options
About this article
Cite this article as:
Solbrig V. Marylou and Koob F. George, Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection, Current Neuropharmacology 2003; 1 (4) . https://dx.doi.org/10.2174/1570159033477035
DOI https://dx.doi.org/10.2174/1570159033477035 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Multivalent & Multifunctional Ligands to β-Amyloid
Current Pharmaceutical Design Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
Current Alzheimer Research Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets Quantitative and Mechanistic Studies of Aβ Immunotherapy
CNS & Neurological Disorders - Drug Targets Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
Current Alzheimer Research Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Current Alzheimer Research Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS
Current Pharmaceutical Design From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Current Medicinal Chemistry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
Current Topics in Medicinal Chemistry Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD): An Update [1]
Medicinal Chemistry Reviews - Online (Discontinued) Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice
Current Alzheimer Research Serial Analysis of Gene Expression in Eukaryotic Pathogens
Infectious Disorders - Drug Targets An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Challenges with Mosquito-borne Viral Diseases: Outbreak of the Monsters
Current Topics in Medicinal Chemistry Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews